TAYLOR BEN R (Chief Financial Officer) sold 2.7% of their position (21.38K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $89.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/30/2025ACC: 0001712276-25-000017
Officer· Chief Financial Officer
Since Feb 2026
-21.38K
Net shares
Net seller
$89.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
21.38K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−21.38K
Price / share
$4.18
Trade value
$89.38K
% of position
2.7%
12/29/2025
782.93K→761.55K
Total
Net shares
−21.38K
Net value
-$89.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/29/2025 | S · Sale | −21.38K | $4.18 | $89.38K | 2.7% | 782.93K | 761.55K |
| Total | −21.38K | -$89.38K | ||||||
Derivative Transactions0
No derivative transactions reported